These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

866 related items for PubMed ID: 29188733

  • 1. Investigational drugs in clinical trials for Hidradenitis Suppurativa.
    Theut Riis P, Thorlacius LR, Jemec GB.
    Expert Opin Investig Drugs; 2018 Jan; 27(1):43-53. PubMed ID: 29188733
    [Abstract] [Full Text] [Related]

  • 2. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials.
    Maarouf M, Clark AK, Lee DE, Shi VY.
    J Dermatolog Treat; 2018 Aug; 29(5):441-449. PubMed ID: 29098911
    [Abstract] [Full Text] [Related]

  • 3. Emerging drugs for the treatment of hidradenitis suppurativa.
    Folkes AS, Hawatmeh FZ, Wong A, Kerdel FA.
    Expert Opin Emerg Drugs; 2020 Sep; 25(3):201-211. PubMed ID: 32667213
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological development in hidradenitis suppurativa.
    Matusiak Ł, Jemec GB, Szepietowski JC.
    Curr Opin Pharmacol; 2019 Jun; 46():65-72. PubMed ID: 31075754
    [Abstract] [Full Text] [Related]

  • 5. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
    Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, Armstrong AW, Kerdel F, Gold MH, Forman SB, Korman NJ, Giamarellos-Bourboulis EJ, Crowley JJ, Lynde C, Reguiai Z, Prens EP, Alwawi E, Mostafa NM, Pinsky B, Sundaram M, Gu Y, Carlson DM, Jemec GB.
    N Engl J Med; 2016 Aug 04; 375(5):422-34. PubMed ID: 27518661
    [Abstract] [Full Text] [Related]

  • 6. Update on Hidradenitis Suppurative (Part II): Treatment.
    Martorell A, García FJ, Jiménez-Gallo D, Pascual JC, Pereyra-Rodríguez J, Salgado L, Villarrasa E.
    Actas Dermosifiliogr; 2015 Nov 04; 106(9):716-24. PubMed ID: 26277040
    [Abstract] [Full Text] [Related]

  • 7. Secukinumab in the treatment of hidradenitis suppurativa.
    Snyder CL, Gibson RS, Porter ML, Kimball AB.
    Immunotherapy; 2023 Dec 04; 15(17):1449-1457. PubMed ID: 37840286
    [Abstract] [Full Text] [Related]

  • 8. Adalimumab: A Review in Hidradenitis Suppurativa.
    Kim ES, Garnock-Jones KP, Keam SJ.
    Am J Clin Dermatol; 2016 Oct 04; 17(5):545-552. PubMed ID: 27665300
    [Abstract] [Full Text] [Related]

  • 9. Management of patients with hidradenitis suppurativa.
    Martorell A, Caballero A, González Lama Y, Jiménez-Gallo D, Lázaro Serrano M, Miranda J, Pascual JC, Salgado-Boquete L, Marín-Jiménez I.
    Actas Dermosifiliogr; 2016 Sep 04; 107 Suppl 2():32-42. PubMed ID: 28081768
    [Abstract] [Full Text] [Related]

  • 10. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC, Bechara FG, Dickinson-Blok JL, Gulliver W, Horváth B, Hughes R, Kimball AB, Kirby B, Martorell A, Podda M, Prens EP, Ring HC, Tzellos T, van der Zee HH, van Straalen KR, Vossen ARJV, Jemec GBE.
    J Eur Acad Dermatol Venereol; 2019 Jan 04; 33(1):19-31. PubMed ID: 30176066
    [Abstract] [Full Text] [Related]

  • 11. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A, Menter A, Armstrong A, Ocampo C, Gu Y, Teixeira HD.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1192-1196. PubMed ID: 27741335
    [Abstract] [Full Text] [Related]

  • 12. Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents.
    Megna M, Bettoli V, Chimenti S, Chiricozzi A, Naldi L, Virgili A, Girolomoni G, Monfrecola G.
    G Ital Dermatol Venereol; 2015 Dec 01; 150(6):731-9. PubMed ID: 26513043
    [Abstract] [Full Text] [Related]

  • 13. Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Tappenden P, Carroll C, Stevens JW, Rawdin A, Grimm S, Clowes M, Kaltenthaler E, Ingram JR, Collier F, Ghazavi M.
    Pharmacoeconomics; 2017 Aug 01; 35(8):805-815. PubMed ID: 28176188
    [Abstract] [Full Text] [Related]

  • 14. Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC.
    Expert Rev Clin Immunol; 2016 Oct 01; 12(10):1015-26. PubMed ID: 27531618
    [Abstract] [Full Text] [Related]

  • 15. Advances in biologic and small molecule therapies for hidradenitis suppurativa.
    Chen SX, Greif C, Gibson RS, Porter ML, Kimball AB.
    Expert Opin Pharmacother; 2022 Jun 01; 23(8):959-978. PubMed ID: 35470765
    [Abstract] [Full Text] [Related]

  • 16. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
    Kimball AB, Sobell JM, Zouboulis CC, Gu Y, Williams DA, Sundaram M, Teixeira HD, Jemec GB.
    J Eur Acad Dermatol Venereol; 2016 Jun 01; 30(6):989-94. PubMed ID: 26201313
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.
    Moyano B, Clemente A, Marín-Jiménez I, Martorell A.
    Actas Dermosifiliogr; 2016 Sep 01; 107 Suppl 2():43-50. PubMed ID: 28081769
    [Abstract] [Full Text] [Related]

  • 18. Target molecules for future hidradenitis suppurativa treatment.
    Zouboulis CC, Frew JW, Giamarellos-Bourboulis EJ, Jemec GBE, Del Marmol V, Marzano AV, Nikolakis G, Sayed CJ, Tzellos T, Wolk K, Prens EP.
    Exp Dermatol; 2021 Jun 01; 30 Suppl 1():8-17. PubMed ID: 34085329
    [Abstract] [Full Text] [Related]

  • 19. Hidradenitis Suppurativa: A Systematic Review and Meta-analysis of Therapeutic Interventions.
    Tchero H, Herlin C, Bekara F, Fluieraru S, Teot L.
    Indian J Dermatol Venereol Leprol; 2019 Jun 01; 85(3):248-257. PubMed ID: 30924446
    [Abstract] [Full Text] [Related]

  • 20. Use of biological treatments in patients with hidradenitis suppurativa.
    Martin-Ezquerra G, Masferrer E, Pujol RM.
    G Ital Dermatol Venereol; 2017 Aug 01; 152(4):373-378. PubMed ID: 27982551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.